LEWIGEIDPSESNTNYNQK* – SIL Vedolozumab signature peptide
LEWIGEIDPSESNTNYNQK Stable Isotope Labeled Vedolozumab (VDZ) peptide serves as an internal standard to confirm VDZ’s primary sequence by mass spectrometry. This allows expected sequences to be confirmed and terminal amino acid homogeneity to be assessed.
SB-PEPTIDE’s Vedolozumab SIL signature peptide quantifier is designed and optimized to provide the best mass spectrometry performance during your Mass Spec assay.
Technical specification
| Sequence : LEWIGEIDPSESNTNYNQ-K*- [K*= K(13C/15N)] | |
| MW : 2 245.28 Da (C97H145N25O36) | |
| Purity : > 95% | |
| Counter-Ion : TFA Salts (see option TFA removal) | |
| Delivery format : Freeze dried in propylene 2mL microtubes | |
| Other name : SIL VDZ signature peptide | |
| Peptide Solubility Guideline | |
| Bulk peptide quantities available |
Price
| Catalog code | Size | Price € | Price $ USD |
| SB298-0.1MG | 0.1 mg | 385 | 481 |